|
|
|
| Clinical Study on Diabetic Intestinal Disease Treated by Pinaverium Bromide Combined with Epalrestat and Methylcobalamin |
| YANG Li, XIN Wei, CUI Shuo, et al |
| Langfang People's Hospital, Hebe Langfang065000, China |
|
|
|
|
Abstract Objective: To investigate the efficacy and feasible mechanism of pinaverium bromide combined with epalrestat and mecobalamin in the treatment of diabetic bowel disease. Methods: A total of 208 patients with type 2 diabetes mellitus complicated with diabetic bowel disease were selected in outpatient and inpatient treatment in Langfang People’s Hospital. 208 outpatients and inpatients meeting the above criteria were randomly divided into two groups. Each group received 104 patients in the treatment group. In both groups, insulin was administered to control blood glucose, and drugs that affect gastrointestinal motility were discontinued before observation. The observation group was treated with methylcobalamin 0.5 μg 3/day orally; the treatment group was on the basis of 0.5 μg of original mecobalamin 3/day orally, combined with pinaverium bromide 50 mg 3/day and epalrestat 50 mg 3/ Oral treatment daily for 3 months. Results:There was no significant difference in clinical data between the two groups (P>0.05). The efficacy of the two groups was significantly higher than that of the observation group. The difference was statistically significant (P<0.05). The scores of diarrhea and constipation and after treatment were compared between the two groups. The scores after treatment in the treatment group were significantly lower than those in the observation group after treatment. The differences were statistically significant. Significance (P<0.05). Conclusion: Pinaverium bromide combined with Epalrestat and Methylcobalamin have significant curative effects on diabetic bowel disease, which is worthy of popularization and application.
|
|
|
|
|
|
[1] 张晓娟,张洁,娄萍萍,等.双歧杆菌四联活菌片治疗32例2型糖尿病肠病效果观察[J].河北医科大学学报,2016,35(5):516~519.
[2] 蒋翠萍,陈一,冯强,等.甲钴胺联合依帕司他治疗2型糖尿病周围神经病变的疗效[J].中国临床药学杂志,2016,25(3):141~144.
[3] 杨硕,李永贵.索利那新联合依帕司他治疗2型糖尿病合并膀胱过度活动症的疗效观察[J].中国糖尿病杂志,2016,25(5):415~419.
[4] 潘焕峰,包塔娜,齐月.肠促胰素对不同BMI的2型糖尿病合并代谢性肝病临床疗效[J].北华大学学报(自然科学版),2018,19(6):768~772.
[5] 甘园园.不同肠内营养输注对缺血性脑卒中合并糖尿病的作用[J].安徽卫生职业技术学院学报,2018,17(5):145~146.
[6] 胡先平,马锐.复方嗜酸乳杆菌联合匹维溴铵治疗腹泻型肠易激综合征效果观察[J].现代消化及介入诊疗,2018,23(03):359~361.
[7] 邱志滨.甲钴胺片与硫辛酸注射液联合依帕司他治疗糖尿病周围神经病变的效果观察[J].河南医学研究,2018,27(22):4156~4157. |
|
|
|
2019, Vol. 25 
